3-49859377-T-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_024046.5(CAMKV):​c.1447A>G​(p.Ser483Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000381 in 1,576,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

CAMKV
NM_024046.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.869
Variant links:
Genes affected
CAMKV (HGNC:28788): (CaM kinase like vesicle associated) Predicted to enable calmodulin binding activity and calmodulin-dependent protein kinase activity. Predicted to be involved in peptidyl-serine phosphorylation. Predicted to be located in cytoplasmic vesicle membrane and plasma membrane. Predicted to be active in glutamatergic synapse and postsynapse. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.089239776).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAMKVNM_024046.5 linkc.1447A>G p.Ser483Gly missense_variant Exon 11 of 11 ENST00000477224.6 NP_076951.2 Q8NCB2-1A0A140VKD5
CAMKVNM_001320147.2 linkc.1354A>G p.Ser452Gly missense_variant Exon 12 of 12 NP_001307076.1 Q8NCB2-3A0A024R331

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAMKVENST00000477224.6 linkc.1447A>G p.Ser483Gly missense_variant Exon 11 of 11 1 NM_024046.5 ENSP00000419195.1 Q8NCB2-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152180
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00000442
AC:
1
AN:
226352
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000183
GnomAD4 exome
AF:
0.00000211
AC:
3
AN:
1424134
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
703398
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32738
American (AMR)
AF:
0.0000477
AC:
2
AN:
41956
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23488
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39276
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80512
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51670
Middle Eastern (MID)
AF:
0.000182
AC:
1
AN:
5502
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1090276
Other (OTH)
AF:
0.00
AC:
0
AN:
58716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152180
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41466
American (AMR)
AF:
0.000131
AC:
2
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000567

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 03, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1447A>G (p.S483G) alteration is located in exon 11 (coding exon 10) of the CAMKV gene. This alteration results from a A to G substitution at nucleotide position 1447, causing the serine (S) at amino acid position 483 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
21
DANN
Benign
0.64
DEOGEN2
Benign
0.052
.;.;T;.;T;T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.49
N
LIST_S2
Benign
0.84
.;T;D;D;D;T
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.089
T;T;T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.34
.;.;N;.;.;.
PhyloP100
0.87
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.66
N;N;N;.;N;N
REVEL
Benign
0.061
Sift
Uncertain
0.013
D;D;D;.;D;D
Sift4G
Benign
0.35
T;T;T;T;.;T
Polyphen
0.0
B;B;B;B;B;B
Vest4
0.19
MutPred
0.12
.;.;Loss of glycosylation at P481 (P = 0.0092);.;.;.;
MVP
0.55
MPC
0.79
ClinPred
0.080
T
GERP RS
1.2
Varity_R
0.045
gMVP
0.15
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1011785677; hg19: chr3-49896810; API